SCHEMBL25815595

SCHEMBL25815595

CC(C)(C)OC(=O)NCCOCCOc1ccc(C=O)cc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.51
ITK Q08881 1/20 0.51
ADRB2 P07550 1/20 0.44
HTR1A P08908 1/20 0.44
BCHE P06276 2/20 0.43
CNR2 P34972 2/20 0.43
SCN9A Q15858 1/20 0.42
AAK1 Q2M2I8 2/20 0.41
FDPS P14324 1/20 0.40
PDK2 Q15119 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
ALDH1A1 P00352 4/20 0.39
HPGD P15428 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25457307 0.90 CA12 (0.46) EGFRITKSCN9AAAK1FDPS
SCHEMBL21549514 0.89 EGFR (0.44) EGFRITKADRB2HTR1ASCN9A
SCHEMBL30444087 0.89 EGFR (0.44) EGFRITKADRB2HTR1ASCN9A
SCHEMBL29948350 0.88 CA12 (0.48) EGFRITKSCN9AAAK1CA12
SCHEMBL20102825 0.88 CA12 (0.48) EGFRITKSCN9AAAK1CA12
SCHEMBL29948353 0.88 CA12 (0.48) EGFRITKSCN9AAAK1CA12
SCHEMBL24838619 0.88 ADRB2 (0.45) EGFRITKADRB2HTR1ABCHE
SCHEMBL18569779 0.88 ADRB2 (0.45) EGFRITKADRB2HTR1ABCHE
SCHEMBL20102815 0.88 CA12 (0.48) EGFRITKSCN9AAAK1CA12
SCHEMBL18544320 0.87 FDPS (0.59) FDPSALDH1A1HPGDCYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023129506-A1 POTENT AND SELECTIVE SMARCA2 DEGRADING CHIMERIC MOLECULES AS CANCER THERAPEUTICS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-07-06 WO disclosed